Asset Management and Custody Banks

Blue Water Acquisition IV

Blue Water Acquisition IV released FY2025 earnings on February 24 (EST) with actual revenue of USD 0 and EPS of USD -0.0467

HCW Biologics

P3 Health Partners

Murano Global BV

Auddia

Super League Enterprise

Trio-Tech Int

Ernexa Therapeutics

Robostrategy

Jiade

BWIV

<p>Maha Capital AB and Blue Water Acquisition Corp. IV have mutually terminated their non-binding Letter of Intent for a proposed SPAC transaction. After further evaluation, both companies decided not to pursue the acquisition of assets. Maha remains focused on its strategic ambition to create a leading fintech platform and will continue to seek opportunities for long-term shareholder value.</p>

Fidelity

Maha and BWIV Terminate the Letter of Intent for Proposed SPAC Transaction

<p>Blue Water Acquisition Corp. IV has mutually terminated its proposed business combination with Maha Capital due to regulatory challenges and timing issues. Despite recognizing the strategic merits of the combination, both parties agreed that unforeseen hurdles made it impractical to proceed. BWAC IV remains active in exploring other opportunities in artificial intelligence, energy, and technology sectors.</p>

prnewswire

18:49 ETBlue Water Acquisition Corp. IV Announces Mutual Termination of Proposed Business Combination with Maha Capital

Earnings Watch

Blue Water Acquisition IV | 10-Q: FY2026 Q1 Revenue: USD 0

Blue Water Acquisition IV(BWIV.US)

Maha and BWIV Terminate the Letter of Intent for Proposed SPAC Transaction

18:49 ETBlue Water Acquisition Corp. IV Announces Mutual Termination of Proposed Business Combination with Maha Capital

Blue Water Acquisition IV | 10-Q: FY2026 Q1 Revenue: USD 0